Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jorge A. Garcia
Observed names:
J. A. Campos Garcia,
Jorge Andres Garcia,
Jorge Andrés García (17688621),
Jorge Garcia,
Jorge García
Institutions:
University Hospitals of Cleveland,
University Hospitals Cleveland Medical Center,
University Hospitals Seidman Cancer Center,
Case Comprehensive Cancer Center,
Case Western Reserve University
Observed institutions:
Cyprus University of Technology,
University Hospitals of Cleveland,
Universidad de Costa Rica,
Tennet (Germany),
University Hospitals Cleveland Medical Center,
University Hospitals Seidman Cancer Center,
Case Comprehensive Cancer Center,
Case Western Reserve University
show all 8
ORCID:
0000-0003-4241-7296
Observed ORCID:
0000-0003-4241-7296
OpenAlex ID:
A5101910444
Coordination of DERs and Flexible Loads to Support Transmission Voltages in Emergency Conditions
2022
·
Francisco Escobar
, Juan M. Viquez
, et al.
·
IEEE Transactions on Sustainable Energy
·
39
PDF
A Combined High-, Medium-, and Low-Voltage Test System for Stability Studies with DERs
2020
·
Francisco Escobar
, Jorge García
, et al.
·
Electric Power Systems Research
·
20
Modeling Framework and Coordination of DER and Flexible Loads for Ancillary Service Provision
2021
·
Jorge García
, Juan Víquez
, et al.
·
Hawaii International Conference on System Sciences (HICSS)
·
9
PDF
Resonance Phenomena and DC Fault Handling During Intersystem Faults in Hybrid AC/DC Transmission Systems with Partial DC Cabling
2018
·
P. Ruffing
, C. Petino
, et al.
·
Power Systems Computation Conference
·
9
Comparison of Ride-Through Characteristics in Aggregate and Detailed Models of DERs
2021
·
Jorge Sancho Chaverri
, Francisco Escobar
, et al.
·
IEEE URUCON
·
5
Durable responses to immune checkpoint inhibitor-based regimens for metastatic clear cell renal cell carcinoma stratified by IMDC risk groups: A pooled analysis of four randomized phase 3 trials
2025
·
Albert Jang
, Jeffrey Y. Zhong
, et al.
·
Kidney Cancer
·
3
Concentraciones en soluciones clínicas: teoría e interconversiones
2002
·
Jorge A. Garcia
·
Revista Costarricense de Ciencias Médicas
·
2
Targeting HER2 in metastatic urothelial carcinoma: a contemporary review
2025
·
Albert Jang
, Nirmala Ghimirey
, et al.
·
ONCOLOGIE
PDF
Impact of variant allele frequency (VAF) of TP53 alterations and Signatera circulating tumor DNA (ctDNA) monitoring for patients (pts) with advanced urothelial carcinoma (aUC) treated with enfortumab vedotin (EV).
2025
·
Albert Jang
, Hamsa L.S. Kumar
, et al.
·
Journal of Clinical Oncology
Supplementary Figure 4B from Angiokines Associated with Targeted Therapy Outcomes in Patients with Non–Clear Cell Renal Cell Carcinoma
2023
·
Andrew J. Armstrong
, Andrew B. Nixon
, et al.
Supplementary Figure 2 from Angiokines Associated with Targeted Therapy Outcomes in Patients with Non–Clear Cell Renal Cell Carcinoma
2023
·
Andrew J. Armstrong
, Andrew B. Nixon
, et al.
Supplementary Figure 3 from Angiokines Associated with Targeted Therapy Outcomes in Patients with Non–Clear Cell Renal Cell Carcinoma
2023
·
Andrew J. Armstrong
, Andrew B. Nixon
, et al.
Mp27-13 Long-term Safety of Darolutamide Among Patients With Metastatic Castration-resistant Prostate Cancer Who Received More Than 4 Years of Therapy
2022
·
Robert Hugh Jones
, Karim Fizazi
, et al.
·
The Journal of Urology
1906 Neoadjuvant Systemic Therapy Vs Early Cystectomy? Single Center Analysis of Outcomes Following Therapy for Patients With Clinically Localized Micropapillary Urothelial Carcinoma of the Bladder
2011
·
Ranko Miocinovic
, Islam A. Ghoneim
, et al.
·
The Journal of Urology
Polar/ET Transmitters: Non-Idealities and Practical Implementation Aspects
2007
·
Christian Fager
, José C. Pedro
, et al.
·
Chalmers Publication Library (Chalmers University of Technology)
Show more works
View as search
Works count:
16
Citation count:
88
H-index:
5
I10-index:
2
Year
Topic
Type